Lycia Therapeutics files for IPO on Nasdaq under symbol LYCA
Lycia Therapeutics has filed for an initial public offering of its common stock on the Nasdaq, aiming to trade under the symbol 'LYCA'. Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, and Lifesci Capital are listed as underwriters.
Lycia Therapeutics said it has filed for an initial public offering of common stock and applied to list the shares on Nasdaq under the symbol LYCA. The company said Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities and LifeSci Capital are underwriting the IPO. Greater than 5% stockholders include entities affiliated with Blue Owl entities.